BlackRock Investment Management, LLC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 208 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.97 and the average weighting 0.2%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$6,112,000
+24.5%
242,062
+21.9%
0.01%
+16.7%
Q3 2016$4,909,000
+27.2%
198,503
+4.8%
0.01%
+20.0%
Q2 2016$3,860,000
+81.7%
189,480
+36.0%
0.01%
+66.7%
Q1 2016$2,124,000
+6.1%
139,290
-6.5%
0.00%0.0%
Q4 2015$2,002,000
+4.7%
148,938
+9.3%
0.00%0.0%
Q3 2015$1,912,000
-17.9%
136,268
-0.7%
0.00%0.0%
Q2 2015$2,330,000
+125.6%
137,239
+60.6%
0.00%
+200.0%
Q1 2015$1,033,000
+46.5%
85,470
+0.6%
0.00%0.0%
Q4 2014$705,000
-5.2%
84,931
-0.8%
0.00%0.0%
Q3 2014$744,000
-19.4%
85,644
+1.6%
0.00%0.0%
Q2 2014$923,000
+89.5%
84,276
+54.8%
0.00%0.0%
Q1 2014$487,000
+46.7%
54,445
+23.7%
0.00%
Q4 2013$332,000
+7.1%
44,025
+4.0%
0.00%
-100.0%
Q3 2013$310,000
+22.5%
42,331
+7.7%
0.00%
Q2 2013$253,00039,3090.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q4 2015
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 426,500$11,754,3403.96%
ASHFORD CAPITAL MANAGEMENT INC 916,747$25,274,7153.72%
ARMISTICE CAPITAL, LLC 5,092,000$140,386,4402.15%
S&T BANK/PA 215,578$5,9431.15%
Aristotle Capital Boston, LLC 1,187,981$32,752,6341.06%
RICE HALL JAMES & ASSOCIATES, LLC 544,468$15,010,9830.95%
Tributary Capital Management, LLC 352,429$9,716,4680.92%
Bridge City Capital, LLC 65,297$1,800,2380.91%
Integral Health Asset Management, LLC 220,000$6,065,4000.84%
Retirement Planning Co of New England, Inc. 51,608$1,422,8330.79%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders